You have mild Sjogren's symptoms. Your genes may be the real culprit.

HLA-DQ2 is a gene that codes for a protein on the surface of your immune cells. This protein acts like a security scanner at the airport of your body. It displays fragments of proteins to your T-cells (the immune soldiers) and essentially says, ‘Is this a threat or not?’ Your immune cells then decide whether to attack based on what HLA-DQ2 is showing them.

Carrying HLA-DQ2 means your immune scanner is set to a particular sensitivity level. Roughly 25-30% of people with European ancestry carry this gene. The problem: if you have HLA-DQ2 and certain other immune variants, your T-cells are more likely to recognize your own gland tissues as threats and mount an attack against them. HLA-DQ2 doesn’t cause Sjogren’s by itself, but it makes your immune system more likely to recognize your moisture glands as foreign.

What this feels like: your immune cells are constantly questioning whether your own tear and salivary glands belong in your body. They see proteins released during normal gland function and interpret them as danger signals. This is the core mechanism of your Sjogren’s.

IRF5 is a transcription factor that acts like the volume dial on your immune system’s loudspeaker. When your immune cells detect a threat (real or misperceived), IRF5 turns on genes that produce inflammatory cytokines. These cytokines are signaling molecules that broadcast, ‘There’s a threat here,’ and recruit more immune cells to the area.

Certain IRF5 variants alter how easily and aggressively this volume gets turned up. People with these variants have a lower threshold for mounting a strong inflammatory response. In the context of Sjogren’s, this means your immune system doesn’t just recognize your gland cells as foreign; it also produces a more intense inflammatory cascade once it does.

What this feels like: inflammation that seems disproportionate to the trigger. Your eyes get drier faster. Your joints ache more intensely. Your fatigue deepens. The inflammation isn’t just present; it’s amplified at the genetic level.

STAT4 is a protein that acts as a molecular switch, directing your immune system toward Th1 and Th17 cell activation. These are specific types of T-cells that produce interferon-gamma and interleukin-17, both of which drive autoimmune responses against tissue. STAT4 is particularly important in determining whether your immune system launches a cellular attack (T-cells directly attacking your glands) versus a humoral attack (B-cells producing antibodies).

STAT4 variants predispose you toward the Th1/Th17 pathway, which means your immune system is more likely to use T-cells to directly attack your own tissues. This is the dominant mechanism in many Sjogren’s cases. If you carry STAT4 variants, your immune system is genetically biased toward cellular autoimmunity.

What this feels like: immune destruction that’s more cell-mediated than antibody-driven. Your gland function declines progressively. Your fatigue is often tied to T-cell activation (it gets worse after immune challenges). You may notice that your symptoms flare after viral infections or environmental stressors.

TNF (tumor necrosis factor-alpha) is one of the most powerful inflammatory cytokines your body produces. It’s a signaling molecule that tells your immune system to increase inflammation, recruit more immune cells, and intensify tissue destruction. In normal amounts, TNF is essential for fighting infections. In excess, it drives autoimmune disease.

The TNF -308G>A variant, carried by roughly 30% of people of European ancestry, increases baseline TNF-alpha production. If you have this variant, your immune system is running a higher baseline level of systemic inflammation even when there’s no active threat. Your inflammatory thermostat is set higher than someone without the variant. In Sjogren’s, this means the inflammatory environment attacking your glands is more intense.

What this feels like: pervasive inflammation that colors everything. Your eyes don’t just feel dry; they feel inflamed. Your joints ache. You have low-grade fevers or night sweats. Your fatigue is sometimes paired with flu-like symptoms. You might notice that anti-inflammatory foods help temporarily, but the baseline feeling of systemic inflammation never fully disappears.

CTLA4 is a critical brake on your immune system. It sits on the surface of T-cells and essentially tells them, ‘Stop. Check your targets. Make sure you’re not attacking yourself.’ This is how your body normally prevents autoimmunity. CTLA4 is the molecule that allows immune tolerance, the biological state where your immune system peacefully coexists with your own tissues.

The CTLA4 +49A>G variant impairs this braking function. Roughly 45% of people carry the G allele. If you have this variant, your T-cells have a weaker brake, which means they’re more likely to keep attacking your own glands even when they should receive the stop signal. This is why Sjogren’s develops and persists.

What this feels like: your immune system doesn’t know when to stop. Once it starts attacking your moisture glands, it keeps going. You don’t have the biological brakes to shut down the response. Symptoms are often progressive rather than stable. You might notice that your Sjogren’s slowly worsens over months or years rather than staying mild indefinitely.

IL-6 is a cytokine that acts as a megaphone for inflammation. When your immune cells are activated, they produce IL-6, which then amplifies the inflammatory response by recruiting more immune cells and increasing vascular permeability (making tissues more swollen and inflamed). IL-6 also crosses the blood-brain barrier and drives neuroinflammation, which is why it’s so strongly linked to fatigue and cognitive symptoms.

The IL6 -174G>C variant, carried by roughly 40% of the population, increases IL-6 production. If you have this variant, your immune system produces more IL-6 in response to any activation signal. This means your inflammatory broadcast is louder than someone without the variant. In Sjogren’s, this translates to more pronounced inflammation in your glands, more systemic symptoms, and often more significant fatigue and brain fog.

What this feels like: inflammation that goes everywhere. Your eyes are dry and inflamed. Your joints ache. Your muscles feel achy (myalgias). Most notably, you have disproportionate fatigue because IL-6 is directly acting on your brain. Brain fog, difficulty concentrating, and post-exertional malaise are common. You might feel like your symptoms are systemic rather than localized.